← Open Payments lookup

PHILLIP GOLDSBOROUGH: Open Payments

NPI 1750081550 · PRINCESS ANNE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$696 in 34 payments from 10 companies in 2025. Trend: 2023 $148 · 2024 $486 · 2025 $696

Food & beverage: $696
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$207
Otsuka America Pharmaceutical, Inc.9$166
E.R. Squibb & Sons, L.L.C.4$75
ABBVIE INC.3$67
Teva Pharmaceuticals USA, Inc.2$39
Lundbeck LLC2$38
Janssen Pharmaceuticals, Inc1$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$31
Axsome Therapeutics, Inc.1$23
Collegium Pharmaceutical, Inc.1$14

Products named: INGREZZA, COBENFY, ABILIFY MAINTENA, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, UZEDY, SPRAVATO.

Industry payments across MD — which companies pay providers there.